FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

27916711000001105: Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Nov 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
87545901000001110 Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106894701000001116 Rizatriptan 10mg tablets (Lupin Healthcare (UK) Ltd) 3 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Is a Rizatriptan 10mg tablets 3 tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has AMP Rizatriptan 10mg tablets (Lupin (Europe) Ltd) true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has specific active ingredient Rizatriptan benzoate true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Has basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (Lupin (Europe) Ltd) 3 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start